ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991

Columbia Next for comprehensive Center Review

February 18, 1977

GAO Calls For Stronger FDA Enforcement Of Accelerated Approval Followup Studies

October 30, 2009

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

Bristol-Myers, Karolinska In Collaboration For Studies.

March 31, 2000

Also in this 8-page issue: Intel Chairman Andrew Grove slams NCI director and cancer program for “wishful dreams” and “chemo speeches,” recommends moratorium on funding for cancer research.

May 14, 2004